Items where Author is "Kesselheim, Aaron S."

Article

Naci, Huseyin, Forrest, Robin, Zhai, Mike, Stofesky, Amanda R. and Kesselheim, Aaron S. (2023) Characteristics of prior authorization policies for new drugs in Medicare Part D. JAMA Health Forum, 4 (2). ISSN 2689-0186

Feldman, William B., Tu, S. Sean, Alhiary, Rasha, Kesselheim, Aaron S. and Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2023) Manufacturer revenue on inhalers after expiration of primary patents, 2000-2021. JAMA, 329 (1). 87 - 89. ISSN 0098-7484

Cherla, Avi, Mossialos, Elias ORCID: 0000-0001-8664-9297, Salcher-Konrad, Maximilian ORCID: 0000-0002-5628-5266, Kesselheim, Aaron S. and Naci, Huseyin (2022) Post-marketing requirements for cancer drugs approved by the European Medicines Agency, 2004-2014. Clinical Pharmacology and Therapeutics, 112 (4). 846 - 852. ISSN 0009-9236

Naci, Huseyin, Kyriopoulos, Ilias-Ioannis, Feldman, William B., Hwang, Thomas J., Kesselheim, Aaron S. and Chandra, Amitabh (2022) Coverage of new drugs in Medicare Part D. Milbank Quarterly, 100 (2). 562 - 588. ISSN 0887-378X

Vokinger, Kerstin N., Hwang, Thomas J., Carl, David L., Laube, Yannic, Ludwig, Wolf Dieter, Naci, Huseyin and Kesselheim, Aaron S. (2022) Price changes and within-class competition of cancer drugs in the USA and Europe: a comparative analysis. The Lancet Oncology, 23 (4). 514 - 520. ISSN 1470-2045

Cherla, Avi, Naci, Huseyin, Kesselheim, Aaron S., Gyawali, Bishal and Mossialos, Elias ORCID: 0000-0001-8664-9297 (2021) Assessment of coverage in England of cancer drugs qualifying for US food and drug administration accelerated approval. JAMA Internal Medicine, 181 (4). 490 - 498. ISSN 2168-6106

Naci, Huseyin, Kesselheim, Aaron S., Rttingen, John Arne, Salanti, Georgia, Vandvik, Per O. and Cipriani, Andrea (2020) Producing and using timely comparative evidence on drugs: lessons from clinical trials for covid-19. The BMJ, 371. ISSN 0959-8146

Vreman, Rick A., Naci, Huseyin, Goettsch, Wim G., Mantel-Teeuwisse, Aukje K., Schneeweiss, Sebastian G., Leufkens, Hubert G.M. and Kesselheim, Aaron S. (2020) Decision making under uncertainty: comparing regulatory and health technology assessment reviews of medicines in the United States and Europe. Clinical Pharmacology and Therapeutics, 108 (2). pp. 350-357. ISSN 0009-9236

Naci, Huseyin and Kesselheim, Aaron S. (2020) Specialty drugs: a distinctly American phenomenon. New England Journal of Medicine, 382 (23). 2179 - 2181. ISSN 0028-4793

Naci, Huseyin, Salcher-Konrad, Maximilian ORCID: 0000-0002-5628-5266, Kesselheim, Aaron S., Dr.rer.nat, Beate Wiesler, Rochaix, Lise, Redberg, Rita, Salanti, Georgia, Jackson, Emily, Garner, Sarah, Stroup, Scott and Cipriani, Andrea (2020) Generating comparative evidence on new drugs and devices before approval. The Lancet, 395 (10228). 986 - 997. ISSN 0140-6736

Naci, Huseyin, Smalley, Katelyn R. and Kesselheim, Aaron S. (2017) Characteristics of preapproval and postapproval studies for drugs granted accelerated approval by the US food and drug administration. JAMA, 318 (7). pp. 626-636. ISSN 0098-7484